🇺🇸 FDA

Drug profile · INN

baclofen

LIORESAL

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

baclofen (LIORESAL) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: intrathecal. Current US regulatory status: approved.

Key facts

INN baclofen
Brand LIORESAL
Route INTRATHECAL
Formulation TABLET, ORALLY DISINTEGRATING
Originator MAIA Biotechnology

Related patents

Search patents →

  1. US 12383522

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12350245

    Stable oral suspensions of baclofen

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12295929

    Intravenous baclofen formulations and treatment methods

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12011502

    Compositions and methods of administering baclofen

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11857524

    Stable oral suspensions of baclofen

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11850225

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11523984

    Compositions and methods of administering baclofen

    Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11491125

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is baclofen?

baclofen (LIORESAL) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: intrathecal. Current US regulatory status: approved.

What is the brand name for baclofen?

LIORESAL is a marketed brand name for baclofen. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of baclofen?

baclofen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.